Magellan Health (MGLN) Misses Q3 EPS by 8c; Lowers FY19 EPS Guidance, Affirms FY19 Revenue Mid-Point Outlookw Below Consensus
Tweet Send to a Friend
Magellan Health (NASDAQ: MGLN) reported Q3 EPS of $1.23, $0.08 worse than the analyst estimate of $1.31. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
